Blog
A new name has entered the weight management conversation. Foundayo, the brand name for orforglipron, was authorised by the Medicines and Healthcare products Regulatory Agency (MHRA) on 10 August 2026, making the UK the first country in Europe to approve this medicine. For anyone researching weight loss treatment options, or searching for Foundayo in Rotherham and across the rest of the UK, here is what the approval actually means, how the tablet works, and, importantly, when you might realistically be able to access it.
At REX Pharmacy, we always recommend speaking to a pharmacist before starting any new weight management treatment, so you can get advice tailored to your own health history.
Quick Answer
Foundayo (orforglipron) is a new once-daily GLP-1 tablet authorised in the UK for weight management and type 2 diabetes. It is not yet available on the NHS but, it was officially launched in UK pharmacies on August 24, 2026, making it available via private prescription. Pharmacies must ensure supply is safe and regulated ahead of prescribing, which is where REX Pharmacy comes in.
- Authorised by the MHRA on 10 August 2026
- A GLP-1 receptor agonist, taken as a tablet rather than an injection
- Approved for weight management and for type 2 diabetes
- Not yet available via the NHS, and not yet routinely available through pharmacies
What Is Foundayo?
Foundayo is the brand name for orforglipron, a new type of GLP-1 receptor agonist. Like other medicines in this class, it works by mimicking a hormone the body naturally produces after eating, called glucagon-like peptide-1 (GLP-1). What makes Foundayo different from many existing options is that it is a tablet rather than an injection, and unlike some other oral GLP-1 medicines, it does not need to be taken on an empty stomach or with any particular food or water restrictions.
It has been authorised in the UK for two separate purposes:
- Weight loss and weight maintenance in adults with a BMI of 30 or above, or a BMI between 27 and 30 alongside at least one weight-related health condition, used together with a reduced-calorie diet and increased physical activity
- Improving blood sugar control in adults with type 2 diabetes that is not well controlled by other means
How Does Foundayo Work?
Foundayo works on the same underlying principle as other GLP-1 medicines, but in tablet form. GLP-1 is a hormone your gut releases naturally after you eat, and it plays a role in telling your brain that you are full. Orforglipron acts on the areas of the brain that regulate appetite, which can help people feel fuller for longer, reduce overall hunger, and decrease food cravings. Over time, alongside dietary and lifestyle changes, this can support meaningful weight loss.
In people with type 2 diabetes, orforglipron also has an effect on blood sugar. It helps to lower blood glucose levels when they are elevated, which is why it has been authorised for both weight management and diabetes care.
Dosing: How Foundayo Is Taken
One of the more patient-friendly aspects of Foundayo is its simplicity of use. It is taken as a tablet once a day, and can be taken at any time of day, with no requirement to take it on an empty stomach or avoid food and drink beforehand. This is a meaningful difference compared with some other oral weight loss medicines currently in use.
Like most GLP-1 medicines, the dose is increased gradually over time to help the body adjust and to reduce the likelihood of side effects. Based on the authorised dosing schedule, treatment is to begin at a low dose and step up through several dose levels, with patients typically remaining on each dose for at least a month before any increase. Anyone who is prescribed Foundayo should always follow the specific instructions given in the Patient Information Leaflet supplied with their medicine.
Foundayo at a Glance
| Feature | Foundayo (Orforglipron) |
|---|---|
| Type of medicine | GLP-1 receptor agonist |
| Form | Oral tablet |
| Frequency | Once daily, any time of day |
| Food or water restrictions | None specified |
| Dose escalation | Gradual, over several dose levels, with a minimum of one month at each level |
| Authorised uses | Weight management and type 2 diabetes |
| UK availability | Authorised by the MHRA, but not yet available via the NHS or routine pharmacy supply |
| Prescription status | Prescription only medicine |
Is Foundayo Available Yet?
This is the most important point for anyone searching for Foundayo in the UK right now: authorisation is not the same as availability. The MHRA’s approval confirms that the medicine meets the required standards of safety, quality, and effectiveness, but it does not automatically mean the medicine is prescribed by GPs, through the NHS.
Before a new medicine like Foundayo becomes routinely available on the NHS, it typically needs to go through further evaluation, including assessment by the National Institute for Health and Care Excellence (NICE), which looks at clinical and cost-effectiveness. This process takes time, and until it is complete, NHS prescribing pathways are unlikely to be in place.
It is also worth noting that, while medication was authorised on 24th August, it can take time for manufacturers to establish full UK supply chains and for pharmacies to be able to order and dispense it.
What Are the Side Effects?
As with other GLP-1 medicines, the most commonly reported side effects involve the digestive system. These include:
- Nausea
- Constipation
- Diarrhoea
- Vomiting
- Indigestion
- Abdominal pain
These effects are often more noticeable when starting treatment or when the dose is increased, and they tend to be discussed and monitored closely by a prescriber as part of ongoing care. As with any new medicine, a full list of side effects and safety information would be provided in the Patient Information Leaflet once the medicine becomes available.
A Word of Caution
Because Foundayo is newly authorised and not consistently available across NHS and some private pathways, it is likely that some sellers, particularly online, may claim to offer it before proper supply chains are in place. All GLP-1 medicines, including Foundayo, are prescription only medicines. This means they can only be obtained legally from a registered pharmacy, with a valid prescription from a doctor or an appropriately qualified prescriber. Buying medicines like this from unregulated or unofficial sellers carries serious health risks, including the possibility of receiving counterfeit, contaminated, or incorrectly dosed products. If you see Foundayo advertised for sale outside of a registered pharmacy, we would strongly encourage caution.
Frequently Asked Questions
Can I get an NHS prescription for Foundayo right now?
Not at this stage. Foundayo has been authorised by the MHRA, but it is not yet available through the NHS supply in the UK. Pharmacies were approved to prescribe or dispense it on 24th August 2026.
Is Foundayo the same as Mounjaro or Wegovy?
No. Foundayo is a different medicine (orforglipron) to Mounjaro (tirzepatide) or Wegovy (semaglutide), although it belongs to a related family of medicines that act on GLP-1 pathways in the body. Mounjaro and Wegovy are already established and available on prescription.
Will Foundayo be available on the NHS?
That has not yet been confirmed. New medicines typically go through further evaluation, including review by NICE, before any decisions are made about NHS availability.
What should I do if I want to lose weight now, rather than wait?
Speak to a pharmacist about the weight management options that are already available and authorised for prescription, such as Mounjaro or Wegovy, which can be discussed and assessed for suitability today.
Is it safe to buy Foundayo online from an unofficial seller?
No. Foundayo is a prescription only medicine and should only ever be obtained from a registered pharmacy with a valid prescription. Buying it from unregulated sellers carries serious health risks.
The Bottom Line
The authorisation of Foundayo is a significant development in weight management and diabetes care, and its tablet form with no food or water restrictions may make it an appealing option for many people in future. However, authorisation is only the first step. Until NHS evaluation is complete and UK supply chains are established, Foundayo is not consistently available across the NHS, and private pharmacies should be used with precaution, as supply of the medication is still in the early stages and some unregulated suppliers may sell counterfeit medication.
If you are interested in exploring a range of weight management options, our team can talk you through what is currently on offer and help you find an approach that suits your health and goals.
You can also get in touch with us if you have any questions.
